Schedule 13D ownership disclosure

BioAmber Inc.

Security class unavailable · CUSIP: 09072Q106

Event date: 2024-09-27

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,227,124
Percent of class
6.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-24-104494
Form type
SC 13D
Filer
BioAge Labs, Inc.
CIK
CIK 1709941
Filed
Sep 30, 2024
Reporting period
Sep 27, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub